3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Colorectal Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Smoking
1
Prostatic Neoplasms
1
Neoplasms
1
Motor Activity
1
Lung Neoplasms
1
Colonic Neoplasms
1
Interventions
Cisplatin
38
Carboplatin
28
Gemcitabine
23
Docetaxel
20
Radiotherapy
18
Etoposide
15
Paclitaxel
13
Erlotinib Hydrochloride
13
Vinorelbine
11
Drug Therapy
11
pembrolizumab
9
aumolertinib
9
apatinib
9
Pemetrexed
9
Gefitinib
9
osimertinib
7
endostar protein
7
Thoracic Surgery, Video-Assisted
7
Blood Specimen Collection
7
camrelizumab
6
anlotinib
6
Vinblastine
6
Surgical Procedures, Operative
6
sintilimab
5
Radiosurgery
5
Fluorodeoxyglucose F18
5
Cyclophosphamide
5
Bevacizumab
5
durvalumab
4
Mitomycin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Lung Neoplasms
×
Motivational Interviewing
×
Clear all
NCT05354882
2023-05-09
DEFACTO2
Université Sorbonne Paris Nord
Phase NA
Unknown
150 enrolled